ARCHIVES

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Patients on Hypertension Meds Lived Longer, Analysis Shows

January 31, 2014

Senate To NCI: Return To Old Guidelines, Stop “Mixed Messages” On Mammography

February 14, 1997

Groups Push for CMS Coverage for LDCT Lung Screening

October 3, 2014

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

November 21, 1975

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

FDA Approves Abbott’s HER-2 DNA Probe Kit.

January 25, 2002